SAN DIEGO (AP) — SAN DIEGO (AP) — Heron Therapeutics Inc. (HRTX) on Tuesday reported a loss of $9.2 million in its second quarter.

On a per-share basis, the San Diego-based company said it had a loss of 6 cents.

The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 4 cents per share.

The pharmaceutical company posted revenue of $36 million in the period, exceeding Street forecasts. Three analysts surveyed by Zacks expected $35.4 million.

Heron Therapeutics expects full-year revenue in the range of $138 million to $158 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on HRTX at https://www.zacks.com/ap/HRTX